Veltassa

Active Ingredient(s): Patiromer
FDA Approved: * October 21, 2015
Pharm Company: * RELYPSA INC
Category: Potassium Levels

Patiromer, sold under the brand name Veltassa, is a medication used to treat high blood potassium.[3] It is taken by mouth.[3] Common side effects include constipation, low blood magnesium, and abdominal pain.[3] It works by binding potassium in the gut.[4][1] It was approved for medical use in the United States in 2015.[3] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Veltassa 8.4 g/1 Oral Powder, for Suspension
NDC: 53436-084
Labeler:
Relypsa, Inc.
Veltassa 16.8 g/1 Oral Powder, for Suspension
NDC: 53436-168
Labeler:
Relypsa, Inc.
Veltassa 25.2 g/1 Oral Powder, for Suspension
NDC: 53436-252
Labeler:
Relypsa, Inc.